Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur Urol. 2014 Apr;65(4):673-4. doi: 10.1016/j.eururo.2013.11.049. Epub 2013 Dec 25.

Penile rehabilitation with phosphodiesterase type 5 inhibitors after nerve-sparing radical prostatectomy: are we targeting the right patients?

Author information

1
San Raffaele Scientific Institute, Urological Research Institute, Milan, Italy.
2
San Raffaele Scientific Institute, Urological Research Institute, Milan, Italy. Electronic address: briganti.alberto@hsr.it.

Abstract

The results reported in all trials comparing chronic versus on-demand phosphodiesterase type 5 inhibitor use after bilateral nerve-sparing radical prostatectomy may be affected by improper patient selection. Targeting the right patients is the key to optimizing the efficacy of these drugs.

PMID:
24388439
DOI:
10.1016/j.eururo.2013.11.049
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center